Adcirca (previously Tadalafil Lilly)-H-C-1021-P46-0019
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
variation-report
medication.label.permit_number
EMA/CHMP/791379/2016
medication.label.permit_validity
First published: 2016-11-24T01:00:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live